Latest On (DERM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-22 20:48 EST | News | Journey Medical Non-GAAP EPS of -$0.30, revenue of $12.2M misses by $3.98M | N/A |  |
| 2023-05-22 20:48 EST | News | Journey Medical Corp (DERM) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-12 22:34 EST | News | Journey Medical Non-GAAP EPS of -$0.42, revenue of $73.7M beats by $1.09M | N/A | |
| 2023-03-31 19:22 EST | News | Journey Medical Non-GAAP EPS of -$0.42, revenue of $73.7M misses by $0.58M | N/A | |
| 2023-03-30 02:57 EST | News | Journey Medical Corp (DERM) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-01-20 17:02 EST | News | Journey Medical CFO Ernest De Paolantonio to step down | N/A | |
| 2022-11-12 21:22 EST | News | Journey Medical Corporation (DERM) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-11 08:38 EST | News | Journey Medical Non-GAAP EPS of -$0.23, revenue of $16.12M misses by $1.53M | N/A | |
| 2022-08-10 15:22 EST | News | Journey Medical Corporation (DERM) CEO Claude Maraoui on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 22:40 EST | News | Journey Medical Non-GAAP EPS of -$0.15, revenue of $18.29M misses by $3.02M | N/A | |
| 2022-05-16 10:53 EST | News | Journey Medical Corporation (DERM) CEO Claude Maraoui on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-11 02:33 EST | News | Journey Medical GAAP EPS of -$0.08 beats by $0.23, revenue of $23.3M beats by $1.14M | N/A | |
| 2022-03-24 08:43 EST | News | Journey Medical Non-GAAP EPS of -$0.93, revenue of $17.52M misses by $2.88M | N/A | |
| 2022-02-11 19:48 EST | News | Journey Medical to get $2.5M as Rapifort gets approval in Japan | N/A | |
| 2022-01-13 13:57 EST | News | Journey Medical, Vyne Therapeutics jump nearly 15% on topical minocycline assets deal | N/A | |
| 2021-12-10 13:34 EST | News | Journey Medical Corporation EPS beats by $1.19, beats on revenue | N/A | |
| 2021-11-12 19:43 EST | News | Commercial stage pharma company, Journey Medical prices $35.2M IPO | N/A | |
| 2021-11-12 00:19 EST | News | Journey Medical Aims For $35 Million IPO | N/A | |
| 2021-11-09 07:06 EST | News | Fortress Bio subsidiary Journey Medical launches IPO | N/A | |
| 2021-10-29 16:42 EST | News | Journey Medical Corporation: Fortress Biotech Subsidiary Files For IPO | N/A | |
| 2020-07-23 16:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 08:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 08:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 04:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 04:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 04:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-03 08:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-11 10:25 EST | News | Incyte details late-stage data on ruxolitinib cream for atopic dermatitis | N/A | |
| 2020-04-09 20:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 12:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 00:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-04 03:27 EST | Analyst Rating | The Analyst Target Price has increased from $21.25 to $25. | Buy | |
| 2020-02-28 03:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 20:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 19:59 EST | Analyst Rating | The Analyst Target Price has decreased from $21.5 to $21.25. | Neutral | |
| 2020-02-24 21:19 EST | Insider Trade | Jason Raleigh Nunn has directly disposed of 6,000 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:51 EST | Insider Trade | Christopher M. Griffith has directly disposed of 67,242 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:51 EST | Insider Trade | Luis C. Pena has directly disposed of 18,233 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:51 EST | Insider Trade | David E Cohen has directly disposed of 35,682 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:51 EST | Insider Trade | Kathleen Sebelius has directly disposed of 6,000 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:51 EST | Insider Trade | THOMAS G WIGGANS has directly disposed of 49,963 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | WILLIAM R RINGO has directly disposed of 6,000 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | FRED B CRAVES has indirectly disposed of 6,000 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | EUGENE A BAUER has directly disposed of 3,726 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | Christopher Horan has directly disposed of 21,400 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | Daljit Singh Aurora has directly disposed of 30,089 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | Lori Lyons-Williams has directly disposed of 25,401 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | Matthew K Fust has directly disposed of 5,051 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | MARK MCDADE has directly disposed of 6,000 shares and currently holds 0 shares. | Sell | |
| 2020-02-24 19:50 EST | Insider Trade | ANDREW GUGGENHIME has directly disposed of 41,951 shares and currently holds 0 shares. | Sell | |
General
- Name
- Symbol
- Type
- Exchange
- Currency
- Country
- Last Split Date
View More
(DERM) Dividend Calendar:
pays out 0% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
(DERM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2018-12-31 | 2019-02-27 | $2.24 million | -$1.70 | -$1.91 | 10.9% |
| 2018-09-30 | 2018-11-08 | $717000 | -$1.58 | -$1.63 | 2.95% |
| 2018-06-30 | 2018-08-07 | $39.08 million | -$0.57 | -$0.51 | -11.94% |
| 2018-03-31 | 2018-05-04 | $299000 | -$1.42 | -$1.36 | -4.16% |
| 2017-12-31 | 2018-02-23 | $1.34 million | -$1.34 | -$1.22 | -10.05% |
| 2017-09-30 | 2017-11-07 | $1.07 million | -$4.30 | -$1.12 | -284.33% |
| 2017-06-30 | 2017-08-08 | $1.07 million | -$0.93 | -$0.89 | -4.28% |
| 2017-03-31 | 2017-05-09 | $1.07 million | -$0.79 | -$0.89 | 11.09% |
| 2016-12-31 | 2017-03-01 | $22.47 million | -$0.21 | -$0.80 | 74.1% |
| 2016-09-30 | 2016-11-08 | $119000 | -$0.72 | -$0.72 | 0% |
| 2016-06-30 | 2016-08-09 | $N/A | -$0.89 | -$0.86 | -3.81% |
| 2016-03-31 | 2016-05-10 | $N/A | -$0.95 | ||
| 2015-12-31 | 2016-03-03 | $N/A | -$1.04 | ||
| 2015-09-30 | 2015-11-11 | $7.3 million | -$0.58 | ||
| 2015-06-30 | 2015-08-14 | $N/A | -$0.69 | ||
| 2015-03-31 | 2015-05-13 | $N/A | -$0.57 | ||
| 2014-12-31 | 2015-03-26 | $7.3 million | -$0.29 | ||
| 2014-09-30 | 2014-11-13 | $N/A | -$0.38 |
(DERM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 | Sep 30 2018 |
|---|---|---|---|---|---|
| Research Development | 18.42 million | 11.3 million | 9.95 million | 8.88 million | 9.09 million |
| Income Before Tax | -57.62 million | -17.96 million | -64.83 million | -71.81 million | -66.54 million |
| Selling General Administrative | 46.36 million | 63.33 million | 48.68 million | 51.79 million | 49.51 million |
| Gross Profit | 9.6 million | 58.33 million | -4.09 million | -8.94 million | -6.72 million |
| Ebit | -55.17 million | -16.3 million | -62.72 million | -69.61 million | -65.32 million |
| Operating Income | -55.17 million | -16.3 million | -62.72 million | -69.61 million | -65.32 million |
| Income Tax Expense | N/A | N/A | N/A | -194000 | N/A |
| Total Revenue | 11.53 million | 66.65 million | 2.45 million | 2.24 million | 717000 |
| Cost of Revenue | 1.93 million | 8.32 million | 6.54 million | 11.18 million | 7.44 million |
| Total Other Income Expense Net | -2.45 million | -1.66 million | -2.11 million | -2.2 million | -1.22 million |
| Net Income From Continuing Operations | -57.62 million | -17.96 million | -64.83 million | -71.81 million | -66.54 million |
| Net Income Applicable to Common Shares | -57.62 million | -17.96 million | -64.83 million | -71.81 million | -66.54 million |
Cash Flow:
| Date | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 | Sep 30 2018 |
|---|---|---|---|---|---|
| Investments | -61.01 million | -37.28 million | 25.52 million | 34.12 million | 51.66 million |
| Change to Liabilities | -1.61 million | -3.03 million | 20.13 million | 2.88 million | 644000 |
| Total Cash Flow from Investing Activities | -61.09 million | -37.3 million | 25.51 million | 4.1 million | 25.63 million |
| Net Borrowings | 38.94 million | N/A | -708000 | 33.24 million | 33.24 million |
| Total Cash Flow from Financial Activities | 38.78 million | 920000 | 139.84 million | 34.2 million | -44000 |
| Change to Operating Activities | 2.72 million | 6.09 million | -25.37 million | -7.79 million | 3.91 million |
| Change in Cash | -28.4 million | -98.54 million | 96.72 million | -40 million | -31.33 million |
| Total Cash from Operating Activities | -6.09 million | -62.16 million | -68.63 million | -78.3 million | -56.92 million |
| Depreciation | 995000 | 978000 | 961000 | 157000 | 154000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | -30 million | -26 million |
| Change to Inventory | -5.82 million | -4.22 million | -4.88 million | -6.4 million | -1.87 million |
| Change to Account Receivables | 48.74 million | -51.35 million | -2.73 million | -3.61 million | -2.06 million |
| Other Cash Flow from Financing Activities | N/A | N/A | -708000 | -708000 | -708000 |
| Change to Net Income | 5.91 million | 6.83 million | 7.5 million | 7.51 million | 7.58 million |
| Capital Expenditures | 82000 | 15000 | 15000 | 21000 | 21000 |
Balance Sheet:
| Date | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 | Sep 30 2018 |
|---|---|---|---|---|---|
| Total Liabailities | 421.76 million | 381.71 million | 386.98 million | 353.36 million | 356.08 million |
| Total Stockholder Equity | 14.48 million | 65.56 million | 74.59 million | -9.04 million | 53.85 million |
| Other Current Liabilities | 20.11 million | 15.08 million | 30 million | N/A | 29.73 million |
| Total Assets | 436.24 million | 447.27 million | 461.58 million | 344.32 million | 409.92 million |
| Common Stock | 55000 | 54000 | 54000 | 42000 | 42000 |
| Other Current Assets | N/A | 25.86 million | 33.37 million | 8.28 million | 9.25 million |
| Retained Earnings | -885.45 million | -827.83 million | -809.87 million | -745.04 million | -673.23 million |
| Other Liabilities | N/A | 6.34 million | N/A | 1.02 million | 1.04 million |
| Other Assets | 6.93 million | 1.12 million | 1.93 million | 3.05 million | 2.86 million |
| Cash | 74.9 million | 103.16 million | 201.69 million | 104.98 million | 144.98 million |
| Total Current Liabilities | 58.64 million | 50.87 million | 62.09 million | 38.56 million | 74.28 million |
| Other Stockholder Equity | 128000 | 113000 | 31000 | -138000 | -151000 |
| Property, Plant & Equipment | 13.12 million | 14.01 million | 14.94 million | 1.18 million | 1.3 million |
| Total Current Assets | 412.52 million | 428.47 million | 443.01 million | 335.41 million | 393.18 million |
| Long Term Investments | 2.03 million | 2 million | N/A | 2.96 million | 10.83 million |
| Net Tangible Assets | 12.83 million | 63.88 million | 72.9 million | -10.76 million | 52.1 million |
| Short Term Investments | 283.23 million | 222.01 million | 186.14 million | 208.06 million | 233.92 million |
| Long Term Debt | 354.42 million | 314.88 million | 314.37 million | 313.79 million | 280.76 million |
| Inventory | 23.51 million | 17.64 million | 13.36 million | 8.37 million | 2.92 million |
| Accounts Payable | 11.25 million | 11.55 million | 6.08 million | 15.95 million | 13.47 million |
(DERM) Chart:
(DERM) News:
Below you will find a list of latest news for (DERM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
(DERM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest DERM Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 4:17 PM EST | 1 | $3.55 |
| Jun 13, 2022 4:56 PM EST | 100 | $3.54 |
| Jun 13, 2022 6:50 PM EST | 100 | $3.535 |
| Jun 13, 2022 7:24 PM EST | 100 | $3.485 |
| Jun 13, 2022 7:56 PM EST | 7 | $3.49 |
(DERM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000083423720009213/0000834237-20-009213-index.htm |
| 2018-11-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1557883/000000000018036454/0000000000-18-036454-index.htm |
| 2019-01-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000003877719000025/0000038777-19-000025-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000003877720000021/0000038777-20-000021-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000008025519002661/0000080255-19-002661-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000021545719007217/0000215457-19-007217-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000083423720008708/0000834237-20-008708-index.htm |
| 2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000083423720009213/0000834237-20-009213-index.htm |
| 2020-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000089924320000939/0000899243-20-000939-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000089924320005280/0000899243-20-005280-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000090221919000112/0000902219-19-000112-index.htm |
| 2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000090221920000057/0000902219-20-000057-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000090221920000354/0000902219-20-000354-index.htm |
| 2020-01-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1557883/000107261320000005/0001072613-20-000005-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000110465920012909/0001104659-20-012909-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000110465920012919/0001104659-20-012919-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000110465920021664/0001104659-20-021664-index.htm |
| 2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1557883/000114036119007534/0001140361-19-007534-index.htm |
| 2019-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1557883/000114036119007536/0001140361-19-007536-index.htm |
| 2019-04-05 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000114420419018402/0001144204-19-018402-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000117266120000501/0001172661-20-000501-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312518289505/0001193125-18-289505-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312518320923/0001193125-18-320923-index.htm |
| 2018-11-07 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1557883/000119312518320976/0001193125-18-320976-index.htm |
| 2018-11-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1557883/000119312518330382/0001193125-18-330382-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519051940/0001193125-19-051940-index.htm |
| 2019-02-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1557883/000119312519052006/0001193125-19-052006-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519055672/0001193125-19-055672-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519077442/0001193125-19-077442-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519078242/0001193125-19-078242-index.htm |
| 2019-03-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1557883/000119312519078452/0001193125-19-078452-index.htm |
| 2019-03-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1557883/000119312519080766/0001193125-19-080766-index.htm |
| 2019-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519080775/0001193125-19-080775-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519139641/0001193125-19-139641-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519169160/0001193125-19-169160-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519180608/0001193125-19-180608-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519215341/0001193125-19-215341-index.htm |
| 2019-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519264848/0001193125-19-264848-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519284714/0001193125-19-284714-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000119312519291030/0001193125-19-291030-index.htm |
| 2020-01-10 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1557883/000119312520005013/0001193125-20-005013-index.htm |
| 2020-01-10 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1557883/000119312520005285/0001193125-20-005285-index.htm |
| 2020-01-10 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/1557883/000119312520005482/0001193125-20-005482-index.htm |
| 2020-01-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1557883/000119312520006095/0001193125-20-006095-index.htm |
| 2020-01-22 | SC TO-T | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1557883/000119312520011457/0001193125-20-011457-index.htm |
| 2020-02-11 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1557883/000119312520031296/0001193125-20-031296-index.htm |
| 2020-02-20 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042773/0001193125-20-042773-index.htm |
| 2020-02-20 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042831/0001193125-20-042831-index.htm |
| 2020-02-20 | POSASR | Post-effective Amendment to an automatic shelf registration statement | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042833/0001193125-20-042833-index.htm |
| 2020-02-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042848/0001193125-20-042848-index.htm |
| 2020-02-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042851/0001193125-20-042851-index.htm |
| 2020-02-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042854/0001193125-20-042854-index.htm |
| 2020-02-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042857/0001193125-20-042857-index.htm |
| 2020-02-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042861/0001193125-20-042861-index.htm |
| 2020-02-20 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1557883/000119312520042862/0001193125-20-042862-index.htm |
| 2020-02-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1557883/000119312520045773/0001193125-20-045773-index.htm |
| 2020-03-02 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1557883/000119312520057798/0001193125-20-057798-index.htm |
| 2019-01-25 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1557883/000131924419000012/0001319244-19-000012-index.htm |
| 2020-02-20 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1557883/000135445720000090/0001354457-20-000090-index.htm |
| 2018-12-31 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1557883/000155788318000001/0001557883-18-000001-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003669/0001562180-18-003669-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003672/0001562180-18-003672-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003674/0001562180-18-003674-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003676/0001562180-18-003676-index.htm |
| 2018-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003677/0001562180-18-003677-index.htm |
| 2018-09-11 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003904/0001562180-18-003904-index.htm |
| 2018-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003905/0001562180-18-003905-index.htm |
| 2018-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218018004253/0001562180-18-004253-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019000996/0001562180-19-000996-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019000997/0001562180-19-000997-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019000998/0001562180-19-000998-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019000999/0001562180-19-000999-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019001000/0001562180-19-001000-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019001001/0001562180-19-001001-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019001002/0001562180-19-001002-index.htm |
| 2019-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019002245/0001562180-19-002245-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003024/0001562180-19-003024-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003025/0001562180-19-003025-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003026/0001562180-19-003026-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003027/0001562180-19-003027-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003028/0001562180-19-003028-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003402/0001562180-19-003402-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003403/0001562180-19-003403-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003404/0001562180-19-003404-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003405/0001562180-19-003405-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003406/0001562180-19-003406-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003407/0001562180-19-003407-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003408/0001562180-19-003408-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003528/0001562180-19-003528-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003529/0001562180-19-003529-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003530/0001562180-19-003530-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003531/0001562180-19-003531-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003532/0001562180-19-003532-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003533/0001562180-19-003533-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003534/0001562180-19-003534-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004388/0001562180-19-004388-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004389/0001562180-19-004389-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004390/0001562180-19-004390-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004391/0001562180-19-004391-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004392/0001562180-19-004392-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004393/0001562180-19-004393-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004818/0001562180-19-004818-index.htm |
| 2019-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019005495/0001562180-19-005495-index.htm |
| 2019-11-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019005496/0001562180-19-005496-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019005497/0001562180-19-005497-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019005498/0001562180-19-005498-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019006079/0001562180-19-006079-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218019006267/0001562180-19-006267-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001612/0001562180-20-001612-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001613/0001562180-20-001613-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001614/0001562180-20-001614-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001615/0001562180-20-001615-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001616/0001562180-20-001616-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001617/0001562180-20-001617-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001619/0001562180-20-001619-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001620/0001562180-20-001620-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001621/0001562180-20-001621-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001622/0001562180-20-001622-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001623/0001562180-20-001623-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001624/0001562180-20-001624-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001625/0001562180-20-001625-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001626/0001562180-20-001626-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001627/0001562180-20-001627-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001638/0001562180-20-001638-index.htm |
| 2018-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000156459018022636/0001564590-18-022636-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1557883/000156459018027992/0001564590-18-027992-index.htm |
| 2018-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000156459018030447/0001564590-18-030447-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000156459019000246/0001564590-19-000246-index.htm |
| 2019-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000156459019002593/0001564590-19-002593-index.htm |
| 2019-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1557883/000156459019004452/0001564590-19-004452-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1557883/000156459019016485/0001564590-19-016485-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1557883/000156459019030036/0001564590-19-030036-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1557883/000156459019040355/0001564590-19-040355-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000156459020000689/0001564590-20-000689-index.htm |
| 2020-01-22 | SC 14D9 | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1557883/000162828020000450/0001628280-20-000450-index.htm |
| 2020-02-10 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1557883/000162828020001243/0001628280-20-001243-index.htm |
| 2020-02-11 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1557883/000162828020001369/0001628280-20-001369-index.htm |
| 2020-02-20 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1557883/000162828020001840/0001628280-20-001840-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1557883/000162828020001842/0001628280-20-001842-index.htm |
| 2018-11-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1557883/999999999518002953/9999999995-18-002953-index.htm |
| 2020-02-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1557883/999999999520000402/9999999995-20-000402-index.htm |
(DERM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of (DERM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: < 1%Institutional Ownership: < 1%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-02-20 | ANDREW GUGGENHIME | CFO | Sell | 41,951.00 | 18.75 | 786,581.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001627/0001562180-20-001627-index.htm |
| 2020-02-20 | Christopher Horan | Chief Technical Ops Officer | Sell | 21,400.00 | 18.75 | 401,250.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001622/0001562180-20-001622-index.htm |
| 2020-02-20 | Christopher M. Griffith | Chief Business & Strategy Off | Sell | 67,242.00 | 18.75 | 1,260,787.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001612/0001562180-20-001612-index.htm |
| 2020-02-20 | Daljit Singh Aurora | Chief Scientific Affairs Off | Sell | 30,089.00 | 18.75 | 564,168.75 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001623/0001562180-20-001623-index.htm |
| 2020-02-20 | David E Cohen | Director | Sell | 35,682.00 | 18.75 | 669,037.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001614/0001562180-20-001614-index.htm |
| 2020-02-20 | EUGENE A BAUER | Chief Medical Officer | Sell | 3,726.00 | 18.75 | 69,862.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001621/0001562180-20-001621-index.htm |
| 2020-02-20 | FRED B CRAVES | Director | Sell | 6,000.00 | 18.75 | 112,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001620/0001562180-20-001620-index.htm |
| 2020-02-20 | Jason Raleigh Nunn | Director | Sell | 6,000.00 | 18.75 | 112,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001638/0001562180-20-001638-index.htm |
| 2020-02-20 | Kathleen Sebelius | Director | Sell | 6,000.00 | 18.75 | 112,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001615/0001562180-20-001615-index.htm |
| 2020-02-20 | Lori Lyons-Williams | Chief Commercial Officer | Sell | 25,401.00 | 18.75 | 476,268.75 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001624/0001562180-20-001624-index.htm |
| 2020-02-20 | Luis C. Pena | Chief Development Officer | Sell | 18,233.00 | 18.75 | 341,868.75 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001613/0001562180-20-001613-index.htm |
| 2020-02-20 | MARK MCDADE | Director | Sell | 6,000.00 | 18.75 | 112,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001626/0001562180-20-001626-index.htm |
| 2020-02-20 | Matthew K Fust | Director | Sell | 5,051.00 | 18.75 | 94,706.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001625/0001562180-20-001625-index.htm |
| 2020-02-20 | THOMAS G WIGGANS | CEO & Chairman of the Board | Sell | 49,963.00 | 18.75 | 936,806.25 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001616/0001562180-20-001616-index.htm |
| 2020-02-20 | WILLIAM R RINGO | Director | Sell | 6,000.00 | 18.75 | 112,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218020001617/0001562180-20-001617-index.htm |
| 2020-02-20 | Eagle Acquisition Corp Bald | 10% Share Holder | Buy | 40,926,025.00 | 18.75 | 767,362,968.75 | 100.00 | https://www.sec.gov/Archives/edgar/data/1557883/000089924320005280/0000899243-20-005280-index.htm |
| 2018-08-15 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 9,000.00 | 100,010.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003674/0001562180-18-003674-index.htm | ||
| 2019-09-12 | Matthew K Fust | Director | Sell | 6,000.00 | 8.77 | 52,636.20 | 11,051.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004818/0001562180-19-004818-index.htm |
| 2018-08-15 | Luis C. Pena | Chief Development Officer | Buy | 1,063.00 | 11,610.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003677/0001562180-18-003677-index.htm | ||
| 2018-08-15 | ANDREW GUGGENHIME | COO and CFO | Buy | 950.00 | 12,165.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003669/0001562180-18-003669-index.htm | ||
| 2019-08-15 | EUGENE A BAUER | Chief Medical Officer | Buy | 2,438.00 | 12,592.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004390/0001562180-19-004390-index.htm | ||
| 2018-08-15 | Luis C. Pena | Chief Development Officer | Buy | 2,437.00 | 14,047.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003677/0001562180-18-003677-index.htm | ||
| 2018-10-19 | Matthew K Fust | Director | Sell | 4,000.00 | 13.75 | 55,000.00 | 14,051.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018004253/0001562180-18-004253-index.htm |
| 2019-08-15 | EUGENE A BAUER | Chief Medical Officer | Buy | 2,850.00 | 15,442.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004390/0001562180-19-004390-index.htm | ||
| 2018-08-15 | ANDREW GUGGENHIME | COO and CFO | Buy | 3,562.00 | 15,727.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003669/0001562180-18-003669-index.htm | ||
| 2018-08-15 | Luis C. Pena | Chief Development Officer | Buy | 3,000.00 | 17,047.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003677/0001562180-18-003677-index.htm | ||
| 2019-06-12 | Matthew K Fust | Director | Buy | 3,000.00 | 17,051.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003532/0001562180-19-003532-index.htm | ||
| 2019-08-19 | Luis C. Pena | Chief Development Officer | Sell | 23,419.00 | 8.54 | 199,998.26 | 17,209.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004393/0001562180-19-004393-index.htm |
| 2019-08-15 | EUGENE A BAUER | Chief Medical Officer | Buy | 2,625.00 | 18,067.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004390/0001562180-19-004390-index.htm | ||
| 2018-08-15 | ANDREW GUGGENHIME | COO and CFO | Buy | 3,563.00 | 19,290.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003669/0001562180-18-003669-index.htm | ||
| 2019-08-15 | Lori Lyons-Williams | Chief Commercial Officer | Buy | 3,189.00 | 26,983.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004392/0001562180-19-004392-index.htm | ||
| 2019-05-17 | Christopher Horan | Chief Technical Ops Officer | Buy | 26,667.00 | 29,071.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003028/0001562180-19-003028-index.htm | ||
| 2018-08-15 | Lori Lyons-Williams | Chief Commercial Officer | Buy | 1,063.00 | 2,984.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003676/0001562180-18-003676-index.htm | ||
| 2019-05-17 | Lori Lyons-Williams | Chief Commercial Officer | Buy | 30,000.00 | 34,168.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003024/0001562180-19-003024-index.htm | ||
| 2019-06-12 | David E Cohen | Director | Buy | 3,000.00 | 35,682.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003533/0001562180-19-003533-index.htm | ||
| 2019-08-15 | Luis C. Pena | Chief Development Officer | Buy | 3,189.00 | 35,893.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004393/0001562180-19-004393-index.htm | ||
| 2019-08-15 | ANDREW GUGGENHIME | CFO | Buy | 2,850.00 | 37,253.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004388/0001562180-19-004388-index.htm | ||
| 2019-08-15 | Luis C. Pena | Chief Development Officer | Buy | 3,000.00 | 38,893.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004393/0001562180-19-004393-index.htm | ||
| 2019-08-19 | Luis C. Pena | Chief Development Officer | Buy | 3,576.00 | 0.99 | 3,525.94 | 40,628.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004393/0001562180-19-004393-index.htm |
| 2019-08-15 | ANDREW GUGGENHIME | CFO | Buy | 3,563.00 | 40,816.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004388/0001562180-19-004388-index.htm | ||
| 2019-08-15 | Luis C. Pena | Chief Development Officer | Buy | 2,438.00 | 41,331.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004393/0001562180-19-004393-index.htm | ||
| 2019-05-17 | Luis C. Pena | Chief Development Officer | Buy | 25,000.00 | 41,349.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003026/0001562180-19-003026-index.htm | ||
| 2019-05-17 | ANDREW GUGGENHIME | CFO | Buy | 25,000.00 | 43,048.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003027/0001562180-19-003027-index.htm | ||
| 2019-04-08 | EUGENE A BAUER | Chief Medical Officer | Buy | 35,000.00 | 1.22 | 42,630.00 | 43,900.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019002245/0001562180-19-002245-index.htm |
| 2019-08-15 | ANDREW GUGGENHIME | CFO | Buy | 3,562.00 | 44,378.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004388/0001562180-19-004388-index.htm | ||
| 2018-08-15 | Christopher M. Griffith | SVP Head Corp. Dev. & Strategy | Buy | 350.00 | 44,558.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003672/0001562180-18-003672-index.htm | ||
| 2018-08-15 | Christopher M. Griffith | SVP Head Corp. Dev. & Strategy | Buy | 469.00 | 45,027.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003672/0001562180-18-003672-index.htm | ||
| 2018-08-15 | Christopher M. Griffith | SVP Head Corp. Dev. & Strategy | Buy | 937.00 | 45,964.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003672/0001562180-18-003672-index.htm | ||
| 2018-08-15 | Christopher M. Griffith | SVP Head Corp. Dev. & Strategy | Buy | 1,079.00 | 47,043.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003672/0001562180-18-003672-index.htm | ||
| 2019-08-15 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 9,000.00 | 48,666.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004389/0001562180-19-004389-index.htm | ||
| 2019-12-24 | Matthew K Fust | Director | Sell | 3,000.00 | 15.00 | 45,000.00 | 5,051.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019006267/0001562180-19-006267-index.htm |
| 2019-08-15 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 9,000.00 | 57,666.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004389/0001562180-19-004389-index.htm | ||
| 2019-06-12 | FRED B CRAVES | Director | Buy | 3,000.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003534/0001562180-19-003534-index.htm | ||
| 2019-06-12 | Jason Raleigh Nunn | Director | Buy | 3,000.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003530/0001562180-19-003530-index.htm | ||
| 2019-06-12 | Kathleen Sebelius | Director | Buy | 3,000.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003529/0001562180-19-003529-index.htm | ||
| 2019-06-12 | MARK MCDADE | Director | Buy | 3,000.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003531/0001562180-19-003531-index.htm | ||
| 2019-06-12 | WILLIAM R RINGO | Director | Buy | 3,000.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003528/0001562180-19-003528-index.htm | ||
| 2019-08-15 | Christopher M. Griffith | Chief Business & Strategy Off | Buy | 938.00 | 64,903.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004391/0001562180-19-004391-index.htm | ||
| 2019-08-15 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 7,500.00 | 65,166.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004389/0001562180-19-004389-index.htm | ||
| 2019-08-15 | Christopher M. Griffith | Chief Business & Strategy Off | Buy | 1,078.00 | 65,981.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004391/0001562180-19-004391-index.htm | ||
| 2019-08-15 | Christopher M. Griffith | Chief Business & Strategy Off | Buy | 1,407.00 | 67,388.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004391/0001562180-19-004391-index.htm | ||
| 2019-08-15 | Christopher M. Griffith | Chief Business & Strategy Off | Buy | 1,050.00 | 68,438.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004391/0001562180-19-004391-index.htm | ||
| 2019-05-17 | Christopher M. Griffith | Chief Business & Strategy Off | Buy | 25,000.00 | 72,610.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019003025/0001562180-19-003025-index.htm | ||
| 2019-08-19 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 23,419.00 | 8.54 | 199,998.26 | 75,940.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019004389/0001562180-19-004389-index.htm |
| 2019-12-12 | Matthew K Fust | Director | Sell | 3,000.00 | 12.00 | 36,000.00 | 8,051.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019006079/0001562180-19-006079-index.htm |
| 2018-08-15 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 2,500.00 | 82,010.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003674/0001562180-18-003674-index.htm | ||
| 2019-04-08 | EUGENE A BAUER | Chief Medical Officer | Sell | 35,000.00 | 15.00 | 525,000.00 | 8,900.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218019002245/0001562180-19-002245-index.htm |
| 2018-08-15 | THOMAS G WIGGANS | CEO & Chairman of the Board | Buy | 9,000.00 | 91,010.00 | https://www.sec.gov/Archives/edgar/data/1557883/000156218018003674/0001562180-18-003674-index.htm |